Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

31 Jan 2007 07:01

Plant Health Care PLC31 January 2007 31 January 2007 Plant Health Care PLC ("Plant Health Care" or "the Company") Directors' Dealings Directors' Exercise of Options The Company was notified on 30 January 2007 that, on the same day, Dr DonaldMarx, a director of the Company, exercised options over 715,761 ordinary sharesof 1p each in the Company ("Ordinary Shares") at an exercise price of 37 penceper Ordinary Share and options over 34,237 Ordinary Shares at an exercise priceof 71 pence per Ordinary Share. Accordingly, on 30 January 2007 Dr Marxexercised a total of 749,998 options over Ordinary Shares. The Company was notified on 30 January 2007 that, on the same day, Mr JohnBrady, a Director of the Company, exercised options over 300,000 Ordinary Sharesat a price of 37 pence per Ordinary Share. Directors' Dealings The Company was notified on 30 January 2007 that, on the same day Dr Marx and MrBrady sold 900,000 Ordinary Shares and 300,000 Ordinary Shares respectively allat a price of 225 pence per Ordinary Share. All of these 1.2 million OrdinaryShares sold by Dr Marx and Mr Brady were as a result of the exercise of options(described above), with the exception of 150,002 Ordinary Shares held by DrMarx. Directors' Interests and Admission of Ordinary Shares Following the exercise of options and share sales described above, thebeneficial interests of the directors in the Company's Ordinary Share capitalare set out below: Name Ordinary Percentage of Share Options Shareholding issued Ordinary Share capital Dr Albert Fischer 143,371 0.35% 225,000John Brady Nil Nil 1,200,000Walter Bratkowski Nil Nil 200,000Dr Robert Chanson 135,166 0.33% 210,000Thomas Isler 400,846 0.97% 202,500Dr Donald Marx 428,813 1.04% 3,470Samuel Wauchope 52,232 0.13% Nil Application has been made for 1,049,998 Ordinary Shares being issued pursuant tothe exercise of options described above, to be admitted to trading on the LondonStock Exchange's AIM market for listed securities ("Admission"). Admission isexpected to occur on 5 February 2007. The New Shares will rank pari passu withthe Company's existing Ordinary Shares. Following admission of the New Shares, the total issued share capital of the Company will be 41,428,422 Ordinary Shares, all of which have voting rights. The above figure (41,428,422) may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Plant Health Care plc underthe FSA's Disclosure and Transparency Rules. For further information: Tavistock ComunicationsJeremy Carey/Matt RidsdaleTel: +44 20 7920 3150 Plant Health Care PLCAndrew Wood, Company Secretary Tel: +44 (0) 20 8866 5702 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20221:46 pmRNSNotice of results and investor presentation
11th Apr 202212:52 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNew Distribution agreement with Ager Agro
14th Mar 202212:49 pmRNSHolding(s) in Company
11th Mar 202212:19 pmRNSHolding(s) in Company
3rd Feb 202212:56 pmRNSHolding(s) in Company
1st Feb 20221:16 pmEQSPlant Health Care, plc
1st Feb 20227:00 amRNS2021 Trading Statement
31st Jan 20227:00 amRNSPHC949 product registration submitted to the EPA
17th Jan 20227:00 amRNSInvestor Presentation
15th Dec 20217:00 amRNSWilbur Ellis and Plant Health Care discussion
13th Dec 20217:00 amRNSCommercial scale manufacturer for Saori
30th Nov 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20216:03 pmRNSExercise of Options
22nd Sep 20217:00 amRNSNew agreement with Nutrien for Saori launch
22nd Sep 20217:00 amRNSInterim Report 30 June 2021
21st Sep 20214:41 pmRNSSecond Price Monitoring Extn
21st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSArgentina approves Harpin as a seed treatment
24th Aug 20217:00 amRNSInvestor Presentation
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.